Patents Assigned to LIB THERAPEUTICS, LLC.
  • Compositions comprising PCSK9-binding molecules and methods of use
    Patent number: 11692021
    Abstract: The present disclosure provides pharmaceutical compositions comprising fibronectin based scaffold domain proteins that bind, for example, proprotein convertase subtilisin kexin-9 (PCSK9).
    Type: Grant
    Filed: July 21, 2020
    Date of Patent: July 4, 2023
    Assignee: LIB Therapeutics, LLC
    Inventors: Tracy S. Mitchell, Richard Mealey
  • Compositions comprising PCSK9-binding molecules and methods of use
    Patent number: 10738102
    Abstract: The present disclosure provides pharmaceutical compositions comprising fibronectin based scaffold domain proteins that bind, for example, proprotein convertase subtilisin kexin-9 (PCSK9).
    Type: Grant
    Filed: September 20, 2019
    Date of Patent: August 11, 2020
    Assignee: LIB THERAPEUTICS, LLC.
    Inventors: Tracy S. Mitchell, Richard Mealey